[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-337584-105":3,"detail-sidebar-cat-0-en-105":85,"doc-detail-337584-en":135},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":78,"head_meta":80,"extra_data":82,"updated_unix":84},105,"en","pdcl3-is-a-prognostic-biomarker-associated-with-immune-infiltration-in-hepatocellular-carcinoma","PDCL3 is a prognostic biomarker associated with immune infiltration in hepatocellular carcinoma","","Phosducin-like 3 (PDCL3) is investigated as a prognostic biomarker and mechanistic regulator in hepatocellular carcinoma (LIHC). Bioinformatics and multi-database analyses assess PDCL3 expression, survival outcomes, and PDCL3-related immune pathways using TCGA, GEPIA, UALCAN, HPA, and TIMER. Differential expression and immune infiltration effects are experimentally validated with immunohistochemistry and immunofluorescence, while functional studies in LIHC cells use CCK-8, wound healing, Transwell, and colony formation assays. Results connect high PDCL3 expression to worse staging, reduced immune activity via macrophage infiltration, increased immune checkpoint gene correlations, and enhanced tumor cell proliferation, migration, and invasion.",{"@graph":14,"@context":77},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/pdcl3-is-a-prognostic-biomarker-associated-with-immune-infiltration-in-hepatocellular-carcinoma/337584/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/pdcl3-is-a-prognostic-biomarker-associated-with-immune-infiltration-in-hepatocellular-carcinoma/337584.png","ImageObject",300,407,{"name":42,"@type":43},"Lucas Martin","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",15,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69,73],{"name":60,"@type":61,"acceptedAnswer":62},"What is PDCL3 and why was it studied in hepatocellular carcinoma?","Question",{"text":63,"@type":64},"PDCL3 (Phosducin-like 3) is a conserved protein involved in processes such as angiogenesis and apoptosis. Limited prior research exists on its biological role in hepatocellular carcinoma, prompting an evaluation of its prognostic value and potential mechanisms.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was PDCL3 expression and prognostic value assessed?",{"text":68,"@type":64},"RNA-seq and clinical data were extracted from TCGA to evaluate PDCL3 expression and survival associations. Differential expression was further analyzed using the HPA database, and enrichment analyses (GO/KEGG) were performed for PDCL3-associated genes. TIMER and other platforms were used to explore immune relationships.",{"name":70,"@type":61,"acceptedAnswer":71},"What immune-related findings connect PDCL3 to hepatocellular carcinoma outcomes?",{"text":72,"@type":64},"High PDCL3 expression was associated with worse clinical staging and prognosis in LIHC. Immune analyses indicated decreased tumor immune activity linked to reduced macrophage infiltration, and PDCL3 expression showed positive correlations with multiple immune checkpoint genes.",{"name":74,"@type":61,"acceptedAnswer":75},"What experimental evidence supports PDCL3’s role in tumor behavior?",{"text":76,"@type":64},"Immunohistochemistry and immunofluorescence confirmed higher PDCL3 levels in LIHC tissues compared with adjacent normal tissues. In vitro assays (including CCK-8, wound healing, Transwell, and colony formation) showed that PDCL3 promotes LIHC cell proliferation, migration, invasion, and colony-forming ability.","https://schema.org",{"og:url":32,"og:type":79,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":81,"canonical":32},"index,follow",{"doc_id":83,"site_id":7},337584,1790185382,{"code":4,"msg":86,"data":87},"success",[88,92,96,100,105,110,115,119,124,127,131],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Exam",70,"exam",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},5,"Comic",60,"comic",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},6,"Technology",50,"technology",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":113,"slug":114},7,"Healthcare",40,"healthcare",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":117,"slug":118},8,30,"research-report",{"id":120,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":122,"slug":123},9,"Religion & Spirituality",20,"religion-spirituality",{"id":122,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":122,"slug":126},"World Cup","world-cup",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":128,"slug":130},10,"Lifestyle","lifestyle",{"id":132,"doc_module":4,"doc_module_name":25,"category_name":133,"show_sort_weight":101,"slug":134},19,"General","general",{"code":4,"msg":86,"data":136},{"doc_id":83,"user_id":137,"nickname":42,"user_avatar":138,"doc_module":4,"category_id":116,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":139,"file_id":140,"file_url":141,"file_type":142,"file_size":143,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":144,"language":145,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":146,"faqs":147,"seo_title":148,"seo_description":12,"update_tm":149,"read_time":113,"preview_page_count":33,"preview_urls":150},8796095360427,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Jin et al. European Journal  \nEuropean Journal of Medical Research (2024) 29:177  \n[https://doi.org/10.1186/s40001-024-01787-7](https://doi.org/10.1186/s40001-024-01787-7 of Medical Research)[ of Medical Research](https://doi.org/10.1186/s40001-024-01787-7 of Medical Research)  \n RESEARCH Open Access  \nPDCL3 is a prognostic biomarker associated with immune infiltration in hepatocellular carcinoma  \nWenzhi Jin1†, Ganggang Wang1, Meiyuan Dong2† and Xiaoliang Wang1*  \nAbstract  \nBackground Phosducin-like 3 (PDCL3) is a member of the photoreceptor family, characterized by a thioredoxin-like structural domain and evolutionary conservation. It plays roles in angiogenesis and apoptosis. Despite its significance, research on the biological role of PDCL3 in liver hepatocellular carcinoma (LIHC) remains limited. This study aims to explore the prognostic value and potential mechanisms of PDCL3 in cancer, particularly in LIHC, through bioinformatics analysis.  \nMethods RNA-seq data and corresponding clinical information for pan-cancer and LIHC were extracted  \nfrom theTCGA database to analyze PDCL3 expression and survival prognosis. Differential expression of PDCL3 was analyzed using the HPA database. GO and KEGG enrichment analysis were performed for PDCL3-associated genes. The relationship between PDCL3 expression and various immune cell types was examined using the TIMER website. Clinical samples were collected, and immunohistochemistry and immunofluorescence experiments were conducted to validate the differential expression of PDCL3 in LIHC and normal tissues. In vitro assays, including CCK-8, wound healing, Transwell, and colony formation experiments, were employed to determine the biological functions of PDCL3 in LIHC cells.  \nResults Analysis from TIMER, GEPIA, UALCAN, and HPA databases revealed differential expression of PDCL3 in various tumors. Prognostic analysis from GEPIA and TCGA databases indicated that high PDCL3 expression was associated with poorer clinical staging and prognosis in LIHC. Enrichment analysis of PDCL3-associated genes revealed its involvement in various immune responses. TCGA and TIMER databases showed that high PDCL3 expression in LIHC decreased tumor immune activity by reducing macrophage infiltration. PDCL3 exhibited positive correlations  \nwith multiple immune checkpoint genes. Immunohistochemistry (IHC) and immunofluorescence (IF) experiments confirmed elevated PDCL3 expression in LIHC tissues compared to adjacent normal tissues. In vitro experiments demonstrated that PDCL3 promoted LIHC cell proliferation, migration, invasion, and colony-forming ability.  \nConclusion PDCL3 is highly expressed in various cancer types. Our study suggests that elevated PDCL3 expression in hepatocellular carcinoma is associated with poorer prognosis and may serve as a potential diagnostic biomarker for LIHC. PDCL3 may regulate the biological functions of LIHC by modulating immune infiltration. However, the precise regulatory mechanisms of PDCL3 in cancer warrant further investigation.  \n†Wenzhi Jin, Ganggang Wang, and Meiyuan Dong contributed equally to this work.  \n*Correspondence:  \nXiaoliang Wang  \n[xiaoliangwang2018@163.com](xiaoliangwang2018@163.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the pe","cbCaikjogbX5VHGO","https://ap.wps.com/l/cbCaikjogbX5VHGO","pdf",5370243,16,"English","# Abstract\n# Methods\n# Results\n# Conclusion\n# Keywords\n# Introduction","[{\"question\":\"What is PDCL3 and why was it studied in hepatocellular carcinoma?\",\"answer\":\"PDCL3 (Phosducin-like 3) is a conserved protein involved in processes such as angiogenesis and apoptosis. Limited prior research exists on its biological role in hepatocellular carcinoma, prompting an evaluation of its prognostic value and potential mechanisms.\"},{\"question\":\"How was PDCL3 expression and prognostic value assessed?\",\"answer\":\"RNA-seq and clinical data were extracted from TCGA to evaluate PDCL3 expression and survival associations. Differential expression was further analyzed using the HPA database, and enrichment analyses (GO/KEGG) were performed for PDCL3-associated genes. TIMER and other platforms were used to explore immune relationships.\"},{\"question\":\"What immune-related findings connect PDCL3 to hepatocellular carcinoma outcomes?\",\"answer\":\"High PDCL3 expression was associated with worse clinical staging and prognosis in LIHC. Immune analyses indicated decreased tumor immune activity linked to reduced macrophage infiltration, and PDCL3 expression showed positive correlations with multiple immune checkpoint genes.\"},{\"question\":\"What experimental evidence supports PDCL3’s role in tumor behavior?\",\"answer\":\"Immunohistochemistry and immunofluorescence confirmed higher PDCL3 levels in LIHC tissues compared with adjacent normal tissues. In vitro assays (including CCK-8, wound healing, Transwell, and colony formation) showed that PDCL3 promotes LIHC cell proliferation, migration, invasion, and colony-forming ability.\"}]","PDCL3 is a prognostic biomarker associated with immune infiltration in hepatocellular carcinoma | PDF",1790019682,[151,155,159,163],{"page_no":22,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6bcb4f1332c87b86be0b05fd8a58f351.webp",983,1305,{"page_no":26,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/73cef87251674f2acaa643817eed99a5.webp",982,1304,{"page_no":30,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/767d6d257b801a256d3d13821be254f9.webp",981,1303,{"page_no":33,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d42bf490e0a367561c8661a82a8cc7bc.webp",980,1301]